J. Wayne Cowens

Comparison of PAM50 Risk of Recurrence Score With Onco<i>type</i> DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Mitch Dowsett, Ivana Šestak, Elena López‐Knowles et al. · Journal of Clinical Oncology · 2013 · 632 citations · Full text

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil et al. · Annals of Oncology · 2013 · 392 citations · Full text

Surgical Oncology, Breast Oncology, Recurrence Score +10

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

Michael J. O’Connell, Ian C. Lavery, Greg Yothers et al. · Journal of Clinical Oncology · 2010 · 298 citations

Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score

Ivana Šestak, Jack Cuzick, Mitch Dowsett et al. · Journal of Clinical Oncology · 2014 · 242 citations · Full text

Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer

Ivana Šestak, Mitch Dowsett, Lila Zabaglo et al. · JNCI Journal of the National Cancer Institute · 2013 · 219 citations · Full text